Patients enrolled in select federal health insurance programs could have up to $500 of hemp-derived products covered each year beginning as early as April 1, according to new details about the ...

A new pilot program to reimburse qualifying Medicare patients in Kentucky for hemp-derived products starts this month.

The Food and Drug Administration (FDA) has issued guidance making clear that it does not intend to interfere with ...

"A federal pilot built on the 0.3% THC loophole is reshaping cannabinoid access policy-without FDA approval, without reimbursement transparency, and without advance market notice" stated Duane Boise, ...

The pilot program marks a paradigm shift in the federal government's relationship with the hemp industry and cannabis sativa products.

A new Medicare pilot program launched April 1, for the first time allowing approved health care providers to give eligible ...

A provision in the spending bill that ended the federal government shutdown earlier this month would ban hemp-derived cannabinoid products. The surprise inclusion has sent the sector scrambling, as ...

The FDA is allowing expanded use of hemp-derived CBD products in medical research under certain conditions, while maintaining ...

The ban, aimed at wiping out intoxicating “gas station weed,” may also kill a multibillion dollar CBD wellness market, ...

While only a couple breweries are making these beverages, potential regulatory clarity could pave the way for more.

A small business owner in Columbia claims a sweeping cannabis bill will put him out of business.  Ethan Jones dealt with ...

A provision in the recent federal spending bill would ban a wide range of hemp-derived cannabinoid products starting in November 2026. The proposal closes the hemp “loophole,” stemming from the 2018 ...